M

    McKesson Corporation (MCK)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $884.46
    -8.93 (-1.00%)

    Market Cap: $104.16B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +7.19%
    Streak
    9 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$10.76
    Range$10.53 - $11.26
    16 analysts
    EPS Revisions
    4
    0
    7d
    3
    4
    30d
    EPS Estimate Drift
    90d ago$10.78+0.2%
    60d ago$10.74-0.1%
    30d ago$10.75-0.1%
    7d ago$10.77+0.1%
    Current$10.76
    Revenue Consensus
    $109.9B
    Range$108.8B - $110.8B
    14 analysts
    Dec 31, 2026
    EPS Consensus$11.00
    Range$10.41 - $11.66
    16 analysts
    EPS Revisions
    1
    0
    7d
    1
    7
    30d
    EPS Estimate Drift
    90d ago$11.26+2.3%
    60d ago$11.21+1.9%
    30d ago$11.03+0.3%
    7d ago$11.00-0.1%
    Current$11.00
    Revenue Consensus
    $113.2B
    Range$112.1B - $114.0B
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$13.33---
    Dec 26EST
    		-$11.00---
    Sep 26EST
    		-$10.76---
    Jun 26
    		$9.93$9.44+5.19%Beat+20.2%
    Mar 26
    		$11.69$11.57+1.04%Beat+15.5%
    Dec 25
    		$9.34$9.27+0.76%Beat+16.3%
    Sep 25
    		$9.86$8.92+10.54%Beat+39.5%
    Jun 25
    		$8.26$8.15+1.35%Beat+4.8%
    Mar 25
    		$10.12$9.83+2.95%Beat+63.8%
    Dec 24
    		$8.03$7.99+0.50%Beat+3.7%
    Sep 24
    		$7.07$6.87+2.91%Beat+13.5%
    Jun 24
    		$7.88$7.21+9.29%Beat+8.4%
    Mar 24
    		$6.18$6.36-2.83%Miss-14.0%
    Dec 23
    		$7.74$7.05+9.79%Beat+12.2%
    Sep 23
    		$6.23$6.15+1.30%Beat+2.8%
    Jun 23
    		$7.27$5.87+23.85%Beat+24.7%
    Mar 23
    		$7.19$7.12+0.98%Beat+23.3%
    Dec 22
    		$6.90$6.36+8.49%Beat+12.2%
    Sep 22
    		$6.06$6.10-0.66%Miss-1.5%
    Jun 22
    		$5.83$5.30+10.00%Beat+4.9%
    Mar 22
    		$5.83$6.04-3.48%Miss+15.4%
    Dec 21
    		$6.15$5.42+13.47%Beat+33.7%
    Sep 21
    		$6.15$4.66+31.97%Beat+28.1%
    Jun 21
    		$5.56$4.14+34.30%Beat+100.7%
    Mar 21
    		$5.05$5.05+0.00%Beat+18.3%
    Dec 20
    		$4.60$4.13+11.38%Beat+20.7%
    Sep 20
    		$4.80$3.88+23.71%Beat+33.3%
    Jun 20
    		$2.77$2.39+15.90%Beat-16.3%
    Mar 20
    		$4.27$4.10+4.15%Beat+15.7%
    Dec 19
    		$3.81$3.49+9.17%Beat+12.1%
    Sep 19
    		$3.60$3.59+0.28%Beat+0.0%
    Jun 19
    		$3.31$3.01+9.97%Beat+14.1%
    Mar 19
    		$3.69$3.66+0.82%Beat+5.7%
    Dec 18
    		$3.40$3.16+7.59%Beat-0.3%
    Sep 18
    		$3.60$3.28+9.76%Beat+9.8%
    Jun 18
    		$2.90$2.89+0.35%Beat+17.9%
    Mar 18
    		$3.49$3.56-1.97%Miss+2.0%
    Dec 17
    		$3.41$2.95+15.59%Beat+11.8%
    Sep 17
    		$3.28$2.79+17.56%Beat+11.6%
    Jun 17
    		$2.46$2.83-13.07%Miss-
    Mar 17
    		$3.42$3.01+13.62%Beat-
    Dec 16
    		$3.05$2.91+4.81%Beat-
    Sep 16
    		$2.94$3.05-3.61%Miss-

    Dividends

    Dividend Metrics

    Yield0.37%
    Annual/Share$3.28
    Payout Ratio5.68%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+14.85%
    5Y CAGR+13.01%
    View MCK's full dividend history

    Key Metrics

    Valuation
    P/E Ratio21.67EV/EBITDA14.71x
    Price/FCF16.36xFCF Yield6.11%
    Profitability
    Profit Margin1.12%Operating Margin1.35%
    ROE0.00%ROIC100.67%
    Financial Health
    Debt/Equity-2.29xInterest Coverage24.48x
    Current Ratio0.89xQuick Ratio0.52x
    Trading Statistics
    Beta0.31Avg Volume1.02M
    52-Week High$997.9052-Week Low$680.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$876.45
    SMA 20$872.96
    SMA 50$834.79
    SMA 200$841.06
    EMA 10$881.30
    EMA 20$871.44
    EMA 50$846.66
    EMA 200$818.85

    MACD

    Line: 13.86Signal: 13.66Hist: 0.20

    ADX

    ADX: 21.8+DI: 32.7-DI: 22.7

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down24.0
    PSAR$845.38

    Bollinger Bands

    Upper Band$912.44
    Lower Band$833.47
    %B Position905%(Upper)
    Band Width0.65

    RSI (14-Day)

    Neutral
    55.6

    Momentum Oscillators

    Stoch %K64.4
    Stoch %D70.1
    Williams %R-41.9
    ROC (10d)2.9%
    Momentum24.54
    CCI (20d)53.9
    MFI (14d)54.5

    Volatility Measures

    ATR (14d)$23.83(2.7%)
    StdDev (20d)19.74
    Hist Vol33.6%(Moderate)

    Volume Flow

    VWAP$884.58
    OBV10.8M
    AD Line-26.4M
    CMF (20d)-0.032

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio1.3x
    VWMA (20d)$872.51

    Pivot Points

    R3$908.23
    R2$904.23
    R1$898.81
    Pivot Point$894.80
    S1$889.38
    S2$885.38
    S3$879.96

    Advanced Oscillators

    TSI13.42
    Ultimate Osc56.4
    KST51.92

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$105.38B$96.30B$106.16B$103.15B$97.83B$90.82B$95.29B$93.65B$79.28B$76.36B$80.90B$77.22B
    Cost of Revenue$101.69B$92.25B$102.47B$99.61B$94.55B$87.18B$92.01B$90.40B$76.13B$72.77B$77.75B$74.15B
    Gross Profit$3.69B$4.04B$3.69B$3.54B$3.28B$3.64B$3.28B$3.25B$3.15B$3.58B$3.15B$3.07B
    Operating Expenses$2.37B$1.89B$2.07B$2.13B$2.24B$2.05B$2.06B$2.67B$2.12B$2.37B$2.51B$2.12B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$2.26B$1.80B$2.03B$2.07B$2.20B$1.98B$2.03B$2.50B$2.00B$2.19B$2.51B$2.09B
    Operating Income$1.32B$2.15B$1.62B$1.41B$1.04B$1.59B$1.22B$578.00M$1.03B$1.22B$642.00M$951.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$77.00M$61.00M$63.00M$74.00M$49.00M$45.00M$67.00M$78.00M$75.00M$80.00M$64.00M$61.00M
    Income Before Tax$1.31B$2.13B$1.63B$1.40B$1.05B$1.51B$1.23B$534.00M$1.08B$1.17B$612.00M$916.00M
    Income Tax Expense$276.00M$270.00M$380.00M$232.00M$220.00M$209.00M$298.00M$247.00M$124.00M$340.00M$-18,000,000$213.00M
    Net Income$1.03B$1.85B$1.25B$1.16B$831.00M$1.31B$928.00M$287.00M$960.00M$830.00M$630.00M$703.00M
    EBITDA$1.58B$2.38B$1.88B$1.66B$1.26B$1.71B$1.45B$775.00M$1.33B$1.41B$835.00M$1.13B
    EBIT$1.39B$2.19B$1.69B$1.47B$1.10B$1.56B$1.29B$612.00M$1.16B$1.25B$676.00M$977.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MCK

    Government Contracts

    Gov Obligations (TTM)
    $12.26B
    Gov Obligations / Revenue
    3.0%
    Obligations YoY
    5.5%
    Active Awards
    2,482
    New Awards (TTM)
    2,005
    Avg Remaining Term
    5.3 mo

    Top agency: Department of Veterans Affairs at 96.8% of trailing twelve month obligations across 7 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24026K1002Department of Veterans AffairsDepartment of Veterans Affairs$1.41BNov 1, 2025
    36C24026K1008Department of Veterans AffairsDepartment of Veterans Affairs$1.40BMay 1, 2026
    36C24026K1007Department of Veterans AffairsDepartment of Veterans Affairs$1.19BApr 1, 2026
    36C24026K1001Department of Veterans AffairsDepartment of Veterans Affairs$1.18BOct 1, 2025
    36C24025K1012Department of Veterans AffairsDepartment of Veterans Affairs$1.18BSep 1, 2025
    36C24026K1006Department of Veterans AffairsDepartment of Veterans Affairs$1.18BMar 1, 2026
    36C24026K1003Department of Veterans AffairsDepartment of Veterans Affairs$1.11BDec 1, 2025
    36C24026K1004Department of Veterans AffairsDepartment of Veterans Affairs$1.09BJan 1, 2026
    36C24025K1011Department of Veterans AffairsDepartment of Veterans Affairs$1.08BAug 1, 2025
    36C24026K1005Department of Veterans AffairsDepartment of Veterans Affairs$1.06BFeb 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Gartner Research: Healthcare Supply Chain Leaders Must Transition to Self-Managing AI Inventory Rooms

    Gartner advises healthcare Chief Supply Chain Officers (CSCOs) to replace manual inventory counting with autonomous supply rooms utilizing computer vision and artificial intelligence. These AI-driven rooms autonomously monitor inventory, predict demand, and trigger reorders, freeing up clinical staff from manual tasks. Gartner emphasizes evaluating new technologies based on their ability to eliminate physical labor rather than just speeding it up, allowing nurses more time with patients.

    HIT Consultant•8/28/26•
    Somewhat-Bullish

    McKesson makes $2.25bn bet on Precision Medicine's future

    McKesson Corporation is acquiring Precision Medicine Group for $2.25 billion, aiming to strengthen its position in oncology and expand its clinical research and biopharma commercialization services. This acquisition will integrate Precision's drug development capabilities, including biomarker intelligence and clinical trial management, into McKesson's existing network. The deal is intended to fill gaps in McKesson's service portfolio and support the increasing demand for comprehensive solutions in the precision medicine field.

    BioXconomy•8/27/26•
    Bullish

    McKesson to Acquire Precision Medicine Group to Strengthen Services

    McKesson Corporation announced its definitive agreement to acquire Precision Medicine Group for approximately $2.25 billion. This acquisition aims to strengthen McKesson's oncology and multispecialty strategy by enhancing its clinical research and biopharma commercialization capabilities. The transaction is expected to support recurring revenue growth and improve McKesson's competitive position in the life sciences market.

    Yahoo Finance•8/27/26•
    Bullish

    McKesson (MCK) Moves Deeper Into Oncology And Clinical Research

    McKesson (MCK) announced its acquisition of Precision Medicine Group, signaling a strategic move to expand its oncology and clinical research services. This acquisition is expected to enhance McKesson's capabilities in personalized medicine, clinical trial support, and biopharma commercialization, aligning with its focus on specialty care. The deal is seen as supportive for McKesson's narrative of moving into higher-value services, though integration risks remain.

    Sahm•8/27/26•
    Bullish

    Henry Schein Market Sentiment

    This article provides an overview of Henry Schein (HSIC) market sentiment, including analyst consensus, short interest, and recent analyst actions. The consensus rating is "Overweight" with an average price target of $88. The article also highlights recent insider selling activity.

    Benzinga España•8/27/26•
    Neutral

    Frequently Asked Questions About MCK

    What is MCK's current dividend yield?
    McKesson Corporation (MCK) has a current dividend yield of 0.37%.
    Does MCK pay dividends?
    Yes, McKesson Corporation pays dividends with a current yield of 0.37%.
    What is MCK's P/E ratio?
    McKesson Corporation has a price-to-earnings (P/E) ratio of 21.67.
    What is MCK's market cap?
    McKesson Corporation (MCK) has a market capitalization of $104.16B with a current stock price of $884.46.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In